A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting

Autor: Clemons, M. a, b, c, ∗, Dranitsaris, G. d, Sienkiewicz, M. b, Sehdev, S. a, Ng, T. a, Robinson, A. e, Mates, M. e, Hsu, T. a, McGee, S. a, Freedman, O. f, Kumar, V. g, Fergusson, D. c, Hutton, B. c, Vandermeer, L. b, Hilton, J. a, b
Zdroj: In The Breast December 2020 54:278-285
Databáze: ScienceDirect